PPARA and metabolic dysfunction-associated steatotic liver disease: The underlying cause of liver fat accumulation in NAFLD is mostly due to the inhibition of fatty acid catabolism, in which PPARα has been continuously suggested as a target molecule for pathogenesis and treatment of NAFLD [36].